Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Cardiol. May 26, 2023; 15(5): 253-261
Published online May 26, 2023. doi: 10.4330/wjc.v15.i5.253
Table 1 Characteristics of aortic stenosis patients with different grades of mitral regurgitation

0 or 1+ MR
2+ MR
3 or 4+ MR
P value
Age (yr)70 ± 1274 ± 972 ± 13< 0.05
Women (%)4448510.4
Syncope (%)3440.85
Angina (%)3849470.12
Dyspnea (%)3938620.002
Atrial fibrillation (%)2432330.18
Hypertension (%)5857440.06
Diabetes mellitus (%)2422180.4
Coronary artery disease (%)5360580.3
Renal insufficiency (%)108130.39
LV end-diastolic diameter (mm)48 ± 748 ± 456 +10< 0.0001
LV end-diastolic dimeter index (mm/m2)26 ± 427 ± 423 + 6< 0.0001
Left ventricular end-systolic diameter (mm)31 ± 933 ± 9 41 + 13< 0.0001
LV end-systolic dimeter index (mm/m2)16 ± 418 ± 4 41 + 13< 0.0001
Ventricular septum (mm)14 ± 214 ± 314 + 30.2
Posterior wall (mm)13 ± 213 ± 212 ± 20.13
Relative wall thickness0.57 + 0.150.57 + 0.130.48 + 0.130.0006
LV ejection fraction (%)62 ± 1654 ± 1745 ± 21< 0.0001
Left atrial dimension (mm)41 ± 943 ± 848 ± 6< 0.0001
Aortic valve area (cm2)0.72 + 0.160.68 + 0.160.70 + 0.200.18
Aortic valve peak gradient (mmHg)73 ± 2371 ± 2667 +220.09
Aortic valve mean gradient (mmHg)45 ± 1543 ± 1741 +150.08
Aortic regurgitation grade0.65+0.831.16+0.911.00+1.00< 0.0001
Mitral E/A velocity ratio1.00 + 0.531.09 + 0.641.60 + 0.67< 0.0001
Mitral E wave deceleration time (ms)270 ± 105278 ± 112194 +890.0001
Pulmonary artery systolic pressure (mmHg)40 ± 1345 ± 2053 +14< 0.0001
Beta-blocker use (%)4646270.02
ACEI or ARB use (%)2533360.12
Digoxin use (%)3532380.47
Statin use (%)3121350.09
Coronary artery bypass grafting (%)3849470.12
Mitral valve repair (%)3220< 0.0001
Mitral valve replacement (%)210130.06
Table 2 Results of Cox regression analysis on the effect of mitral regurgitation on survival
Variable
χ2 value
P value
LV end-diastolic dimension10.4< 0.01
LV ejection fraction23.3< 0.0001
Mitral regurgitation7.9< 0.01